Merck Serono Ventures
Funding early innovation
Merck Serono Ventures is a strategic, corporate venture capital fund that invests in emerging biotechnology companies. The fund was started in 2009 with the mandate to invest in early-stage innovative technologies.
Our investments focus on innovative technologies with the potential to impact Merck Serono's focus therapeutic areas: Oncology, Neurodegenerative Diseases, Rheumatology, Fertility and Endocrinology.
As strategic investors, we strive to bring our support to portfolio companies through continued interaction with our internal experts in various areas providing key insights into strategic research planning, marketing and clinical development. We have a streamlined decision-making process to evaluate investment opportunities and enable us to make critical investment decisions faster.
Companies wishing to submit proposals or receive additional information can contact Merck Serono Ventures through the link on this page.
